Latest filing published 29 Jun 2018 for Eloxx Pharmaceuticals, Inc..
No signal scores available.
All filings by Silvia Noiman on record concern Eloxx Pharmaceuticals, Inc. The record holds 2 filings, for trades running from 6 June 2018 to 15 June 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 29 June 2018: an option exercise, in Eloxx Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations